← Back to headlines
Moderna and BioNTech Shares Surge Amid Renewed Interest in mRNA Technology
Pharmaceutical stocks Moderna and BioNTech have seen significant price increases as investors reassess the commercial viability and pipeline strength of messenger RNA therapies beyond vaccines.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Meta Reaches $17 Billion Settlement in Social Media Addiction Lawsuits
18m ago
NextNRG Secures 25-Year Microgrid Contract for Florida Medical Facility
28m ago
Chinese AI Firm Moonshot Negotiates Revenue Deals With US Tech Giants
41m ago
French Astronaut Performs Spacewalk; Meteorite Hunters Seek Universe Clues
42m ago